Biogen Inc. (NASDAQ:BIIB) analysts raised to Buy from Neutral with a 400 price target at Mizuho. Stifel raised its rating to Buy from Hold with a 415 price target. The consensus analyst target was 336.79 ahead of the calls, and Biogen has a 52-wk trading range of 244.28 – 344.37.
Netflix Inc. (NASDAQ:NFLX) Jefferies reiterated its Hold rating and raised its target to 190 from 180, and Wedbush maintained its Underperform rating while raising its target to 93 from 88 based on cash flow burn. FBR Capital Markets reiterated its Buy rating but raised its target to 207 from172. Loop Capital reiterated its Buy rating and raised its target to 242 from 228.
UnitedHealth Group Inc. (NYSE:UNH) analysts started with an Outperform rating and assigned a 250 price target at BMO Capital Markets. It has a consensus target price of 211.78 and a 52-wk trading range of 136.22 to 200.76. This is now the highest price target on Wall Street, as Thomson Reuters showed the prior street-high target at 235.
Latest posts by Paul Ebeling (see all)
- Less Reporting Buy Public Companies Finally on the Table - August 17, 2018
- President Trump, “I think Bruce Ohr is a disgrace” - August 17, 2018
- Governor Cuomo Disparages America, President Trump Hammers Him - August 17, 2018